Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy

BACKGROUND: The mechanism of tumor immune escape and progression in colorectal cancer (CRC) is widely investigated in-vitro to help understand and identify agents that might play a crucial role in response to treatment and improve the overall survival of CRC patients. Several mechanisms of immune es...

Descripción completa

Detalles Bibliográficos
Autores principales: Taib, Nassiba, Merhi, Maysaloun, Inchakalody, Varghese, Mestiri, Sarra, Hydrose, Shereena, Makni-Maalej, Karama, Raza, Afsheen, Sahir, Fairooz, Azizi, Fouad, Nizamuddin, Parveen B., Fernandes, Queenie, Yoosuf, Zeenath Safira K. M., Almoghrabi, Salam, Al-Zaidan, Lobna, Shablak, Alaaeldin, Uddin, Shahab, Maccalli, Cristina, Al Homsi, Mohammed Ussama, Dermime, Said
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067322/
https://www.ncbi.nlm.nih.gov/pubmed/37004094
http://dx.doi.org/10.1186/s12967-023-04073-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067322/
https://www.ncbi.nlm.nih.gov/pubmed/37004094
http://dx.doi.org/10.1186/s12967-023-04073-y

Ejemplares similares